Venker Eric
SEC insider (Form 3/4/5 filer). CIK 0001801917. Chief Executive Officer at Immunovant, Inc. (IMVT) and 1 other issuer. 123 reported Form 4/5 transactions since Sep 2024; latest on Oct 20, 2026. Located in LONDON.
Companies Venker Eric has filed insider reports for
- Immunovant, Inc. (IMVT): Director, Officer, Chief Executive Officer
- Roivant Sciences Ltd. (ROIV): Officer, President & Immunovant CEO
Venker Eric
CIK: 0001801917
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (123 total)
- Oct 20, 2026ROIV
Roivant Sciences Ltd.
SaleDirect14.1K shares at avg. $35.42$501K - Oct 20, 2026ROIV
Roivant Sciences Ltd.
SaleDirect185.9K shares at avg. $35.09$6.5M - Oct 2, 2026IMVT
Immunovant, Inc.
SaleDirect3.5K shares at avg. $34.11$120K - Oct 1, 2026IMVT
Immunovant, Inc.
DispositionDirect85.9K shares at avg. $33.65$2.9M - Oct 1, 2026IMVT
Immunovant, Inc.
ExerciseDirect92.2K shares at avg. $14.46$1.3M - Sep 30, 2026ROIV
Roivant Sciences Ltd.
SaleDirect200K shares at avg. $36.62$7.3M - Sep 30, 2026ROIV
Roivant Sciences Ltd.
ExerciseDirect200K shares at avg. $3.85$770K - Aug 28, 2026ROIV
Roivant Sciences Ltd.
SaleDirect33.8K shares at avg. $36.44$1.2M - Aug 28, 2026ROIV
Roivant Sciences Ltd.
ExerciseDirect200K shares at avg. $3.85$770K - Aug 28, 2026ROIV
Roivant Sciences Ltd.
SaleDirect166.2K shares at avg. $35.63$5.9M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 20, 2026 |  ROIV Roivant Sciences Ltd. | Sale | 14,144 | $35.42 | $500,980 | Direct |
| Oct 20, 2026 | ROIV Roivant Sciences Ltd. | Sale | 185,856 | $35.09 | $6,521,687 | Direct |
| Oct 2, 2026 |  IMVT Immunovant, Inc. | Sale | 3,506 | $34.11 | $119,590 | Direct |
| Oct 1, 2026 | IMVT Immunovant, Inc. | Disposition | 85,886 | $33.65 | $2,890,064 | Direct |
| Oct 1, 2026 | IMVT Immunovant, Inc. | Exercise | 92,187 | $14.46 | $1,333,024 | Direct |
| Sep 30, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $36.62 | $7,324,000 | Direct |
| Sep 30, 2026 | ROIV Roivant Sciences Ltd. | Exercise | 200,000 | $3.85 | $770,000 | Direct |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Sale | 33,818 | $36.44 | $1,232,328 | Direct |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Exercise | 200,000 | $3.85 | $770,000 | Direct |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Sale | 166,182 | $35.63 | $5,921,065 | Direct |
1-10 of 123 transactions